High levels of KYNA in the prefrontal cortex of patients with schizophrenia can be due to reduced activity of kynurenine 3-monooxygenase (KMO), because reduction in KMO expression and its enzyme activity have been reported in the patient’s brain [21]. This evidence concerns the gene KMO and schizophrenia.